Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05VEV
|
|||
Former ID |
DNC006566
|
|||
Drug Name |
Ac-hPhe-Leu-Ala-LeuVSMe
|
|||
Synonyms |
CHEMBL207579; Ac-hPhe-Leu-Ala-LeuVSMe
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C29H46N4O6S
|
|||
Canonical SMILES |
CC(C)CC(C=CS(=O)(=O)C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCC1=CC=CC=C1)NC(=O)C
|
|||
InChI |
1S/C29H46N4O6S/c1-19(2)17-24(15-16-40(7,38)39)32-27(35)21(5)30-29(37)26(18-20(3)4)33-28(36)25(31-22(6)34)14-13-23-11-9-8-10-12-23/h8-12,15-16,19-21,24-26H,13-14,17-18H2,1-7H3,(H,30,37)(H,31,34)(H,32,35)(H,33,36)/b16-15+/t21-,24+,25-,26-/m0/s1
|
|||
InChIKey |
WUQZWLVEKPBGGU-WXIXLNPNSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Cathepsin B (CTSB) | Target Info | Inhibitor | [1] |
Cathepsin S (CTSS) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Lysosome | |||
Antigen processing and presentation | ||||
Phagosome | ||||
Tuberculosis | ||||
NetPath Pathway | TCR Signaling Pathway | |||
IL2 Signaling Pathway | ||||
Leptin Signaling Pathway | ||||
Reactome | Collagen degradation | |||
Trafficking and processing of endosomal TLR | ||||
Assembly of collagen fibrils and other multimeric structures | ||||
MHC class II antigen presentation | ||||
Endosomal/Vacuolar pathway | ||||
Degradation of the extracellular matrix | ||||
WikiPathways | Class I MHC mediated antigen processing & presentation | |||
Trafficking and processing of endosomal TLR |
References | Top | |||
---|---|---|---|---|
REF 1 | Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and c... J Med Chem. 2006 May 18;49(10):2953-68. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.